Evidence map›Paper›PMID 39624726›Full record

SynthesisFrontiers in microbiology2024

Harnessing AI for advancing pathogenic microbiology: a bibliometric and topic modeling approach.

Tian Tian, Xuan Zhang, Fei Zhang, Xinghe Huang, Minglin Li, Ziwei Quan, Wenyue Wang, Jiawei Lei, Yuting Wang, Ying Liu and 1 more

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. [Advances in the Application of Artificial Intelligence in Clinical Microbiological Testing].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026
    Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Tian Tian *Department of Family Medicine, Shengjing Hospital of China Medical University, Shenyang, China.
Xuan Zhang *Department of Family Medicine, Shengjing Hospital of China Medical University, Shenyang, China.
Fei ZhangDepartment of Family Medicine, Shengjing Hospital of China Medical University, Shenyang, China.
Xinghe HuangCollege of Metrology and Measurement Engineering, China Jiliang University, Hangzhou, China.
Minglin LiDepartment of Family Medicine, Shengjing Hospital of China Medical University, Shenyang, China.
Ziwei QuanDepartment of Family Medicine, Shengjing Hospital of China Medical University, Shenyang, China.
Wenyue WangDepartment of General Practice, The First Hospital of China Medical University, Shenyang, China.
Jiawei LeiDepartment of Family Medicine, Shengjing Hospital of China Medical University, Shenyang, China.
Yuting WangDepartment of Cardiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
Ying LiuDepartment of Nephrology, Shengjing Hospital of China Medical University, Shenyang, China.
Jia-He WangDepartment of Family Medicine, Shengjing Hospital of China Medical University, Shenyang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The integration of artificial intelligence (AI) in pathogenic microbiology has accelerated research and innovation. This study aims to explore the evolution and trends of AI applications in this domain, providing insights into how AI is transforming research and practice in pathogenic microbiology. Methods: We employed bibliometric analysis and topic modeling to examine 27,420 publications from the Web of Science Core Collection, covering the period from 2010 to 2024. These methods enabled us to identify key trends, research areas, and the geographical distribution of research efforts. Results: Since 2016, there has been an exponential increase in AI-related publications, with significant contributions from China and the USA. Our analysis identified eight major AI application areas: pathogen detection, antibiotic resistance prediction, transmission modeling, genomic analysis, therapeutic optimization, ecological profiling, vaccine development, and data management systems. Notably, we found significant lexical overlaps between these areas, especially between drug resistance and vaccine development, suggesting an interconnected research landscape. Discussion: AI is increasingly moving from laboratory research to clinical applications, enhancing hospital operations and public health strategies. It plays a vital role in optimizing pathogen detection, improving diagnostic speed, treatment efficacy, and disease control, particularly through advancements in rapid antibiotic susceptibility testing and COVID-19 vaccine development. This study highlights the current status, progress, and challenges of AI in pathogenic microbiology, guiding future research directions, resource allocation, and policy-making.

Indexed as

antimicrobial resistance (AMR)artificial intelligence (AI)bibliometricsdeep learning (DL)machine learning (ML)pathogenic microorganismstopic modeling

Identifiers

PMID39624726
PMCPMC11610450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.